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2Abstract: Site-directed mutagenesis is a traditional approach for structure-function analysis of 
protein tyrosine kinases, and it requires the generation, expression, purification, and analysis of 
each mutant enzyme. In this study, we report a versatile high throughput bacterial screening 
system that can identify functional kinase mutants by immunological detection of tyrosine 
phosphorylation. Two key features of this screening system are noteworthy. First, instead of 
blotting bacterial colonies directly from Agar plates to nitrocellulose membrane, the colonies 
were cultured in 96-well plates, and then spotted in duplicate onto the membrane with 
appropriate controls. This made the screening much more reliable compared to direct colony 
blotting transfer. A second feature is the parallel use of a protein tyrosine phosphatase (PTP)-
expressing host and a non-PTP-expressing host. Because high activity Src mutants are toxic to 
the host, the PTP system allowed the identification of Src mutants with high activity, while the 
non-PTP system identified Src mutants with low activity. This approach was applied to Src 
mutant libraries randomized in the highly conserved HRD motif in the catalytic loop, and 
revealed that structurally diverse residues can replace the His and Arg residues, while the Asp 
residue is irreplaceable for catalytic activity. 
Keywords: Src protein tyrosine kinase, catalytic loop, HRD motif, bacterial colony screening.
Impact statement: Protein tyrosine kinases are a large family of regulatory enzymes associated 
with cancer development. Structural variations among protein tyrosine kinases determine their 
function and regulation in the cells. Identifying structure-function relationships is essential for 
understanding their catalytic and regulatory mechanisms and for drug development. This study 
presents a versatile approach for identifying functional mutants of protein tyrosine kinase, in the 
effort to establish protein tyrosine kinase structure-function relationships. 
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31. Introduction 
  Protein tyrosine kinases (PTKs)1 are important signaling proteins and anticancer drug 
targets[1, 2]. A full understanding of their biological roles in normal and pathological conditions, 
and rational inhibitor design require an understanding of the structural basis of PTK catalysis, 
regulation, and substrate specificity. The catalytic domains of PTKs are generally similar, 
sharing many residues essential for structural integrity, catalysis, and regulation [3, 4]. 
Elucidating the roles of evolutionarily conserved as well as variable residues in PTK catalysis, 
regulation or structural integrity requires extensive research using multidisciplinary tools, such as 
biochemistry, structural biology and biophysics. 
One useful tool for this research is site-directed mutagenesis and heterologous 
expression. A residue in a kinase can be replaced by any other standard amino acid residue and 
the mutant enzyme can often be readily expressed in an appropriate bacterial host. Upon 
purification of a mutant enzyme, it can be characterized to determine the effects of the mutation. 
The challenge with this approach is that it is time-consuming because each mutant needs to be 
expressed, purified and characterized. Considering that each residue could require up to 19 
mutants for a full analysis, the challenge grows exponentially with the addition of each residue to 
analyze. Furthermore, when a mutant has no catalytic activity, the effect of the mutation 
becomes difficult to characterize. It would therefore be desirable to develop a convenient and 
high throughput screening system in bacteria to identify active PTK variants from a library of 
mutants.  
There are several challenges in developing this approach. First, while some PTKs can be 
readily expressed in bacteria, others are toxic to the bacterial host [5, 6]. This toxicity is due to 
the phosphorylation of bacterial proteins by the heterologous PTK, but can be overcome by the 
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4co-expression of a protein tyrosine phosphatase (PTP) [6-9]. Second, expression of PTKs in a 
bacterial host is often plagued by other generic issues, such as differences in codon usage 
between higher organisms and bacteria, protein folding and solubility [10]. Solutions to each of 
these problems have been developed. Plasmids that express tRNAs rarely used in bacteria can 
help alleviate the codon usage problem [11, 12], while co-expression of chaperones, such as 
GroES/EL can help heterologous PTK fold more efficiently [13-16].  
In this study, we developed a bacterially based rapid high throughput screening method that 
incorporates each of these elements. We validate this system by using it to study the functionality 
of the HRD motif in the protein tyrosine kinase Src.  The HRD motif is the first three residues in 
the highly conserved catalytic loop of protein kinases [17]. In Src, The HRD motif is three 
residues 384-386. Asp386 of this motif is the catalytic base, and is considered indispensable for 
catalysis [18-22]. His384 and Arg385 have been thought to be key regulatory residues as their 
interactions vary in different activity states of several kinases [20, 23-28]; however their exact 
roles in PTK regulation have not been fully defined. This study confirms that the Asp386 residue 
is indeed essential for catalysis as previously demonstrated, while the His384 and Arg385 can be 
replaced by a wide variety of residues without abolishing kinase activity. 
2. Results 
2.1. Bacterial proteins are phosphorylated on tyrosine residues when PTKs are 
heterologously expressed in E coli. For screening of active PTKs or mutants in bacteria, it would 
be desirable if the kinases phosphorylate bacterial proteins that can be detected by Western 
blotting using anti-phosphotyrosine antibodies. It will then spare the need to express a specific 
substrate for the kinase in the bacterial cells. To confirm that eukaryotic PTKs phosphorylate 
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5bacterial proteins, four protein tyrosine kinases, Abl, Csk, FGFR1, and Lck were each cloned 
into pGEX-4T-1 and the plasmids were introduced into E. coli DH5α (hereafter called E. coli). 
Fig. 1A shows a Western blot detecting protein tyrosine phosphorylation after the bacteria were 
cultured in LB medium at 370C for 24 hours.  E. coli cells containing the empty expression 
vector did not produce any detectable protein tyrosine phosphorylation (Fig 1A, lane 1). 
Expression of each PTK resulted in significant tyrosine phosphorylation of proteins of various 
sizes. Even with FGFR1, which resulted in relatively low levels of protein phosphorylation, it 
was still readily detectable. 
2.2.  Active Src expression in E. coli requires the co-expression of a protein tyrosine 
phosphatase.  Fully active Src is toxic to E. coli and cannot be expressed unless it is co-
expressed with a PTP [6-9]. While the co-expression of a PTP helps reduce the toxicity 
associated with PTK expression, the PTP might reduce the phosphorylation of bacterial proteins 
to a level that is undetectable by Western blotting. That would preclude phosphotyrosine-based 
screening. We therefore examined whether phosphotyrosine can still be detected in E. coli when 
active Src is co-expressed with a PTP. The wtSrc, kinase-defective Src (kdSrc, containing a 
Lys295Met mutation) [13, 14] and truncated Src (SD-Src: His384 was replaced with Ser, and 
Arg385 replaced with a stop codon) in the pRSET-a plasmid were introduced into E. coli 
BL21(DE3)RIL harboring the pREP4groESL and pCDF-PTP1B plasmids.  The truncated Src 
mutant, SD-Src, was included here because it will be used as a parental plasmid for generating 
Src mutant libraries in later experiments. By mutating the HR residues in the HRD motif to S 
we achieved two purposes: the mutation completely eliminated Src kinase activity and generated 
a restriction site (AGTACT for Sca I) on the plasmid. Using SD-Src as a parental plasmid for 
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6library generation eliminates parental plasmids as false positives in the library screening. 
Incorporating a restriction site allows convenient mutation verification. 
Individual colonies were grown for 24 h at 370C in LB broth. Soluble fractions from the 
cultured cells were analyzed by Western blotting using monoclonal antibodies specific for 
phosphotyrosine or phosphotyrosine 416 of Src, which is the site of Src autophosphorylation 
[29]. The active wtSrc phosphorylated bacterial proteins and Src itself on Tyr416, whereas 
neither kdSrc nor SD-Src resulted in detectable phosphorylation (Fig. 1B).  The presence of the 
PTP significantly reduced the number of proteins phosphorylated on tyrosine compared to those 
by other kinases without the PTP (Fig. 1A and 1B). Even in the presence of the PTP, however, 
the residual phosphotyrosine level was still sufficient for Western blot detection when wtSrc was 
expressed. 
Co-expression of a PTP poses a dilemma for phosphotyrosine-based screening to identify 
active Src mutants. While the expression of wtSrc and Src mutants with high activity requires a 
PTP, co-expression of a PTP may reduce the phosphotyrosine signal to a point as to prevent 
identification of mutants with low activity. As previously demonstrated, low activity Src mutants 
can be expressed in bacteria without the help of a PTP [6]. With the opposing requirements by 
low activity and high activity Src mutants, we introduced each Src mutant library into E. coli co-
expressing the PTP 1B (the PTP system) and E. coli not co-expressing PTP 1B (the non-PTP 
system) for dot blot screening. We anticipated that the more active mutants would likely be 
selected in the PTP system and the less active mutants would likely be selected in the non-PTP 
system.
2.3. Dot blot screening. We explored the dot blotting format to make the screening more high 
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7throughput. There are two general ways of transferring colonies onto a nitrocellulose membrane 
for screening: blotting colonies from an Agar plate onto the membrane directly, or culturing the 
colonies in liquid and dot blotting the cultures on to the membrane. While the former is more 
direct and convenient, it did not work well in our hands. Both the colony size and the blotting 
transfer efficiency from the plate to the membrane varied from colony to colony, resulting in low 
reproducibility. The second approach worked much better and is outlined in Fig. 2B. It involves 
inoculating colonies for overnight individual liquid cultures in 96-well plates, and spotting a 
similar number of cells on the membrane. Positive controls (cells expressing an active kinase) 
and negative controls (cells that do not express an active kinase) can be spotted on the 
membrane, and each can be spotted in duplicate. Using this approach, the detection signals from 
the positive and negative controls consistently reflected the kinase activity expressed.
We tested this screening strategy on Src by determining the residues that can functionally 
replace the HRD motif.  The HRD motif is the first three residues (His384-Arg385-Asp386 in 
Src) in the catalytic loop. Asp386 in Src (or its equivalent in other kinases) is the catalytic base 
[22, 30] in catalyzing the phosphoryl transfer reaction. As such, this Asp residue is thought to be 
essential for catalysis, but it is not clear if any other residue can functionally replace it. His384 
and Arg385 are thought to be important regulatory residues [28, 31], even though the specific 
roles they play in regulation are not clear.  It has been shown that His384 in Src can be replaced 
by several residues and still maintain some level of kinase activity [6]. Mutation of Arg385 to 
Ala results in low kinase activity in v-Src [32], while an Arg to Cys mutation has little effect on 
the kinase activity of Drosophila Src64 [33]. Considering the ambiguous requirements for these 
residues, we thought a thorough evaluation of these positions may be informative, and 
identifying functional HRD mutants of Src would be a good test for the screening system.
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8To apply the high-throughput screening to the HRD motif in Src, we first generated a 
truncated form of Src, SD-Src, in which Ser replaced His384 and a stop codon replaced 
Arg385. With this truncation in the HRD motif, SD-Src loses approximately half of the 
catalytic domain, and all its catalytic activity. The mutant libraries are generated by mutating the 
codons for SD into appropriate codons required for each mutant library, as explained in the 
following sections. The reason we used SD-Src, instead of wtSrc, as the parental plasmid is that 
because SD-Src is catalytically truncated and thus not active, any unmutated parental plasmid 
will not result in a false positive colony during screening.  Otherwise, the false positives from 
unmutated original plasmids would outnumber the active mutants from the mutation library.
2.4. Identification of residues that can replace His384 in the HRD motif. A His384 mutation 
library was created by mutating the S codons in SD-Src to the codons for XRD, where X is 
the randomized residue, while R restored the wt Arg residue at the 385 position. The randomized 
plasmids were introduced into both the non-PTP system and the PTP system, and the colonies 
were subjected to the screen outlined in Fig. 2B. Representative screening results from the PTP 
system and non-PTP system, respectively, are shown in Fig. 3. As shown in the blots, the 
positive controls (wtSrc) consistently produced positive signals while the negative controls 
(kdSrc and SD-Src) consistently produced undetectable signals. When a box containing a 
colony from the mutant library produced two visible signals, the mutant was considered a 
positive. The colonies were then cultured and the plasmids from the positive colonies were 
isolated and sequenced to identify the mutations. 
Approximately 630 random colonies were screened in the PTP system (Fig. 3A), and five 
positives were identified.  All five mutants had histidine at the 384 position, with both CAT and 
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9CAC codons used.  This result indicated that only wild type Src with a His at this position 
generated sufficient tyrosine phosphorylation signal to be selected as a positive in the PTP 
system. In the non-PTP system, ~20 mutants on average were positives for each 96-slot 
screening (Fig. 3B). Fifty random positives were selected and their plasmids were sequenced. 
Nine different mutants, His384Gln, His384Tyr, His384Thr, His384Ser, His384Phe, His384Leu, 
His384Val, His385Ile and His384Gly, were identified. Wild type Src was not identified from the 
non-PTP system, presumably because wtSrc is toxic to E. coli without a PTP. 
To confirm the catalytic activity of the His384 mutants, all nine mutant enzymes were 
expressed and purified. The relative kinase activity of these mutants was determined using 
polyE4Y as a substrate (Fig. 4). All mutants maintained active kinase activity and His385Gln had 
the highest catalytic activity at ~14% of that of the wild type. The functional substitutions for 
His384 were either hydrophobic residues, Phe (10.2%), Leu (1.1%), Val (0.6%) I (0.6%) and Gly 
(0.2%), or polar but not charged residues, Gln (14.2%), Tyr (6.2%), Thr (6.0%) and Ser (2.6%). 
This result supports the proposal that His384 is involved in hydrophobic interactions in 
stabilizing the active conformation [25], and also suggests that His384 may interact with other 
residues through hydrogen bonds in some conformations. 
2.5. Identification of residues that can replace Arg385 in the HRD motif. We next applied this 
strategy to Arg385 by replacing S codons in SD-Src with codons for HX, where H restores 
the His384 and X is randomized residue at the 385 position. Representative screening results 
using the PTP and non-PTP systems are shown in Fig. 5. In both expression systems, a large 
number of positive colonies were identified. Approximately 50 functional mutants were selected 
and sequenced from each screening system. While each system produced its own unique 
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variants, some mutants were found in both systems. Arg385Gln and Arg385Tyr were selected 
only from the non-PTP system, while Arg385Lys, Arg385Val, Arg385Asn, Arg385Leu, 
Arg385Cys and wtSrc were only found in the PTP system. Arg385Ala, Arg385Gly, Arg385Ser, 
and Arg385Thr were selected from both systems. These results suggested that a variety of 
Arg385 mutants maintained significant catalytic activity.
Selected mutants from both systems were purified and the catalytic activity was 
determined (Fig. 6). As expected, many mutants displayed significant kinase activity, with some 
approaching that of wtSrc. It is remarkable that Val, Asn and Cys, with side chains very different 
from each other and from that of Arg, can all replace Arg385 and maintain most of the kinase 
activity. No negatively charged residue was identified at this position from either system. 
2.6. The PTP system and non-PTP system can each accommodate Src mutants with kinase 
activities within a defined range. An examination of the results of all of the above screening 
suggests that the PTP system and the non-PTP system can each accommodate Src mutants with a 
broad range of kinase activities. The 9 mutants selected from the PTP system had kinase 
activities ranging from ~17.2 (Arg385Ser) to 88.3% (Arg385Asn). Because wtSrc was also 
selected from the PTP system, this result indicated that the range of kinase activity that can be 
selected by the PTP system is ~17% to 100% of the wtSrc activity. Mutants with activities below 
17% were likely unable to produce a positive signal due to the PTP dephosphorylation. Among 
the 13 mutants identified from the non-PTP system, including 9 His384 mutants and 4 Arg385 
mutants, Arg385Thr had the highest activity at 30.8%, while His384Gly had the lowest activity 
at 0.2%, indicating that the selective range for the non-PTP system was 0.2% to 31% of the wild 
type activity. The upper limit is likely determined by the threshold of kinase toxicity that can be 
Page 10 of 35
John Wiley & Sons
Protein Science
11
tolerated by the bacterial host cells.
2.7. Identification of residues that can replace Asp386 in the HRD motif. The same approach 
was applied to identify residues that can replace Asp386 in the HRD motif. In generating the 
Asp386 mutants, the codons for SD in SD-Src were replaced with the codons for HRX. The 
HR codons restored the wildtype His and Arg residues at 384 and 385 positions, while the X 
represented the randomized codon for the 386 position. The library was screened in the PTP and 
non-PTP systems, and typical results are shown in Fig. 7. A total of 630 colonies were screened 
in each screening system. Only the PTP system produced positive colonies, and sequencing 
indicated that all the positive colonies contained wtSrc, with Asp386 being coded by either GAT 
or GAC codons. With 630 colonies screened in each system, the probability of any of the 64 
codons not being represented among these colonies in each of the systems is about 0.3%. This 
result indicated that replacing Asp386 by any other residue could not retain even 0.2% of wtSrc 
kinase activity, the lower limit of the non-PTP system. This result supports the assignment of 
Asp386 as an indispensable residue for Src catalysis [20]. 
3. Discussion
We report a bacterially based high throughput screening method for identifying 
functional PTK mutants. This method incorporates all the tools that have been developed to help 
protein kinase expression in bacteria, including expressing rarely used tRNAs in bacteria, co-
expressing a chaperone to help the target PTK fold, and co-expression of a protein tyrosine 
phosphatase to help overcome toxicity associated with the expression of some PTKs. While the 
co-expression of a PTP helps with the expression of a toxic PTK, its inclusion in the screening 
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system results in a bias that favors high activity mutants and prevents the identification of low 
activity mutants. Using parallel PTP and non-PTP systems removes the bias, and enables the 
identification of mutants with all levels of activity.  While such a system may not be necessary 
for all PTKs, it is particularly useful for a toxic PTK, such as Src. Using several small Src mutant 
libraries randomizing the highly conserved HRD motif, the benefits of the parallel PTP and non-
PTP systems became obvious, as each system selected Src mutants with kinase activities that fall 
within a broad range. 
Another important feature of the screening system is how the colonies from Agar plates 
are transferred to a nitrocellulose membrane. Instead of transferring the colonies by directly 
blotting the colonies from the plates to the membrane, each colony was cultured in 96 well 
plates, and comparable number of cells were then dot-blotted onto the filter paper. This 
eliminated the variation in colony size, uneven colony blotting, and also enabled duplication of 
colonies and incorporation of positive and negative controls in the screening. Despite the extra 
step that may limit the number of colonies that can be conveniently screened, this approach is 
superior for most applications. A previous report described colony screening to identify 
substrates for a given kinase [34]. In this earlier study, no PTP and chaperones were used. While 
this method served the purposes of the previous study, the incorporation of the PTP and 
chaperone is necessary to eliminate the bias caused by toxic PTKs. A comparison between the 
results from the PTP and non-PTP systems indicates that the non-PTP system has an inherent 
bias that would have precluded the identification of the high activity Src mutants. 
The screening method was successfully used to identify mutants in the HRD motif of Src 
protein tyrosine kinase. The HRD motif is a highly conserved structural feature in PTKs, and 
among protein kinases in general. It is well established that the Asp386 in the HRD motif is the 
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catalytic base [20, 22]. Consistent with this designation is the extreme conservation at this 
position in the kinome. Among 447 active protein kinases encoded by the human genome, only 
one contains a non-Asp residue, a Ser in IRAK3, at this position[4]. In contrast, among 50 
human pseudokinases, 33 contain a residue other than Asp at the equivalent position. Therefore, 
missing the Asp residue is considered a hallmark of pseudokinases, even though some 
pseudokinases were discovered to possess significant kinase catalytic activity [35-38]. Whether 
Asp can be replaced by any other residue has not been fully tested in any kinase. The screening 
of an Asp386 mutant library indicated that no other residue was able to replace Asp386 to allow 
significant kinase activity in Src (> 0.2% of wild type). 
The roles His384 and Arg385 play in the kinase function are less understood. There are 
considerable variations at these positions even though there is a general conservation in the 
kinome. Among 447 active kinases encoded by the human genome, 52 (12%) contain a non-His 
residue at the position equivalent to His384, including Tyr (44/52), Leu (5/52), Cys (1/52), Phe 
(1/52), and Ile (1/5Most of these residues (except Cys) were also identified in our His384 mutant 
library (Fig. 4). Loss of His at this position is not a defining feature of pseudokinases, as 80% of 
pseudokinases retain a His at this position (compared to 88% among active kinases). 
Furthermore, most of the same residues used by active kinases are also used by pseudokinases. 
Approximately 83% of the 447 active human protein kinases and only 40% pseudokinase contain 
an Arg residue at the position equivalent to Arg385, suggesting that the Arg residue at this 
position is important for the kinase function. Among the 75 protein kinases using a non-Arg 
residue at this position, the top six substitutions are Leu (19/75), Gly (15/75), Cys (9/75), Ala 
(7/75), Thr (5/75) and Lys (5/75). All of these residues could indeed replace Arg to afford Src 
kinase activity in the Arg385 library (Fig. 6). Among the 50 pseudokinases, 20 have an Arg, 18 
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have a Gly, and a small number used Lys (4), Cys (2) among others. Because the similar sets of 
residues are used by the active kinases and peudokinases, the residue at this position does not 
define an active or inactive kinase. It is interesting to note that negatively charged residues, Asp 
or Glu, do not appear at the positions equivalent to H384 or R385 in any active or inactive 
human kinases, and were not selected in the H384 and R385 libraries. A question remains 
unanswered as to why His and Arg are conserved through evolution although they are not 
required in most kinases. It is plausible that conservation is based on certain non-catalytic 
functions unique to some kinases, such as regulation. Protein kinases in different families often 
have unique regulatory mechanisms, yet all the mechanisms are based on a common 
conformational elasticity embedded in the kinase catalytic domain [39-43].  Further studies will 
be needed to determine whether the HRD motif is involved in controlling conformational 
changes underlying kinase regulation.
4. Materials and Methods
4.1. Reagents and chemicals. Consumables, culture media, and media components were 
purchased from Fisher Scientific. The QuikChange mutagenesis kit was purchased from 
Stratagene. Specific antibodies were purchased from Cell Signaling Technology. DNA primers 
were synthesized by Integrated DNA Technologies. The chromatographic resin, Ni-NTA 
agarose, was purchased from Qiagen. Bradford reagent and pre-cast SDS-PAGE gels were 
purchased from Bio-Rad. All the other chemicals were purchased from Sigma.
4.2. Construction of PTK expression plasmids. Wild type human Abl catalytic domain [44], 
full-length Csk [14], FGFR1 catalytic domain [45], and full-length Lck [5] were cloned into 
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pGEX-4T-1 plasmid using BamHI and EcoRI restriction sites as described previously and 
expressed in Escherichia coli DH5α. All constructs were verified by sequence analysis. Plasmids 
were introduced into the specific expression systems by electroporation. 
4.3. Molecular construction of Src and Src mutants and their expression in a PTP system and 
a non-PTP system. Wild type Src was cloned into the pRSETA plasmid using Bam HI and 
HindIII restriction sites as described previously [6, 13, 14]. Kinase-defective Src (kdSrc, 
containing a Lys295Met mutation) [13] and truncated Src (S-Src: His384 was replaced with 
Ser, and Arg385 replaced with a stop codon) were generated by QuikChange site-directed 
mutagenesis. Active Src and Src mutants were expressed in a PTP system (BL21(DE3)RIL 
harboring the pREP4groESL and pCDF-PTP1B plasmid) [13] and a non-PTP system 
(BL21(DE3)RIL harboring the pREP4groESL) [6] for screening purposes.
4.4. Mutant library construction and active mutant screening. A QuikChange mutagenesis kit 
was used for the construction of mutant libraries. The plasmid pRSETA S-Src was used as 
template for the construction of mutant plasmids to avoid wild type Src plasmid contamination in 
constructed libraries. The primers for the His384 mutant library were  5’- 
GGATGAACTACGTGXXXCGAGACCTGCGGGCGG and its complimentary primer. These 
primers changed the His CAC codon to a random sequence (XXX) while keeping all other 
neighboring residues as wildtype. The primers for the Arg385 mutant library were, 5’- 
GGATGAACTACGTGCACXXXGACCTGCGGGCGGCC and its complimentary primer. 
These primers changed the Arg CGA codon to a random sequence (XXX) while keeping all 
other neighboring residues as wildtype.
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The primers for the Asp386 mutant library were 5’- 
GGATGAACTACGTGCACCGAXXXCTGCGGGCGGCCAAC and its complimentary primer.  
These primers changed the Asp GAC codon to a random sequence (XXX) while keeping all 
other neighboring residues as wildtype.
QuikChange was performed as instructed by the manufacturer. The constructed mutant 
plasmids were transformed into a PTP-system (BL21(DE3)RIL harboring the pREP4groESL and 
pCDF-PTP1B plasmids) and a non-PTP system (BL21(DE3)RIL harboring the pREP4groESL). 
Mutant colonies were inoculated into 96-well plates containing 200 l in LB broth in each well 
with appropriate antibiotics. The plates were incubated for 24 h at 370C shaking at 250 rpm. 
Then two 0.4 µl samples from each well (representing approximately 8x105 cells) were blotted 
directly onto a nitrocellulose membrane. The membrane was heated at 950C for 5 min to lyse the 
cells and blocked with milk. This was followed by immunoblotting using a mouse monoclonal 
antibody against phosphotyrosine (PY100; Cell Signaling Technology) and an anti-mouse 
secondary antibody conjugated to horseradish peroxidase (HRP) (Stratagene). 
4.5. Expression and purification of Src and active Src mutants. As described above, wild type 
Src and active Src mutants were expressed in Escherichia coli BL21(DE3)RIL cells harboring 
the pREP4groESL plasmid and pCDF-PTP1B by the use of the pRSETA plasmid as described 
[6]. The plasmid pREP4groESL contains the genes for the GroES/EL chaperone, which helps 
Src fold correctly [13]. The pCDF-PTP1B directs the expression of PTP1B, which keeps Src and 
bacterial proteins dephosphorylated and reduces the toxicity of Src expression to bacterial cells 
[7]. The (His)6-tagged active Src constructs were purified using immobilized Ni-iminodiacetic 
acid-agarose as described previously [46]. Briefly, individual colonies were inoculated into 500 
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mL of LB culture medium containing appropriate antibiotics. The cultures were grown to an 
OD600 of 2.5 and diluted with 500 mL of fresh LB containing the antibiotics. The cultures were 
air-cooled to room temperature, and 0.4 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) 
was added to induce the production of the fusion protein. Cultures were allowed to induce for 6 h 
at room temperature with shaking at 250 rpm. Bacterial cultures were harvested by centrifugation 
at 4,500g and stored at -20 °C before use.  Cell pellets were resuspended with ice-cold lysis 
buffer [50 mM Hepes (pH 8.0), 200 mM NaCl, 10 mM imidazole, and 0.1% Triton-X]. Cells 
were lysed by French press and clarified by centrifugation at 47,800g for 30 min at 4 °C. The 
supernatant was added to 0.75 mL of Ni-NTA agarose (Qiagen) and gently mixed by rotation at 
4 °C for 30 min. The beads were loaded into a column and then washed with washing buffer (50 
mM Hepes, pH 8.0, and 20 mM imidazole). Proteins were eluted by using 100–300 mM 
imidazole in 50 mM Hepes (pH 8.0). Enzymes were desalted and stored in 50 mM Hepes (pH 
8.0) at -20 °C in 40% glycerol. Protein concentration was determined by Bradford reagent 
standardized with BSA (0.2–1.0 mg/ml). Purity of protein fractions was determined by 
SDS/PAGE (Bio-Rad) and stained with Coomassie blue. 
4.6. Kinase assay. The kinase activity of wild type Src and Src mutants was determined by a 
luminescent ADP detection assay (ADP-GloTM Kinase Assay, Promega) using polyE4Y and ATP 
as substrates. The phosphorylation reactions were performed in 50 l volumes at 25oC in the 
protein kinase assay buffer: 50 mM N-(2-hydroxyethyl)piperazine-N′-3-propanesulfonic acid (pH 
8.0) containing 5% glycerol, 0.005% Triton X-100, and 0.05% 2-mercaptoethanol. The standard 
assay used 12 mM MgCl2, 0.2 mM ATP, and 1 mg/ml polyE4Y. After a 30 min incubation, 5 l 
of the kinase reaction mixture was mixed with 5 l ADP-GloTM reagent and incubated for 40 min 
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to stop the kinase reaction and deplete the unconsumed ATP. Kinase detection reagent (10 l) 
was added and the mixture was incubated for another 30 min to convert produced ADP to ATP 
and introduce luciferase and luciferin to detect converted ATP. Then the luminescence produced 
was measured by a plate-reading luminometer. Assays were performed in duplicate, and each 
assay was repeated three times with reproducible results. 
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Figure 1. Protein tyrosine phosphorylation by PTKs when expressed in E coli. (A) Protein 
phosphorylation by Abl, Csk, FGFR1 and Lck. As described in the Materials and Methods 
section, E. coli cells expressing these kinases were collected from overnight cultures and 
analyzed by Western Blotting with a monoclonal antibody specific for phosphotyrosine residues. 
The same amount of soluble cell lysates for each PTK sample were compared. (B) Protein 
tyrosine phosphorylation by Src when it is co-expressed with a protein tyrosine phosphatase in E. 
coli. The wtSrc and Src mutants were co-expressed with GroESL in the PTP system. The wtSrc, 
kdSrc, and SD-Src were expressed at 370C for 24 hours. The same amount of soluble lysates 
were analyzed by Western Blotting with monoclonal antibodies specific for phosphotyrosine and 
phosphor-Tyr416, respectively.
Figure 2. Schemes of library construction and proposed screening strategy. A. Construction 
of SD-Src and HRD mutant libraries. B. Colony screening. Individual steps are depicted and 
labeled, and explained in detail in Materials and Methods.
Figure 3. Representative screening results of His384 mutation library. The His384 mutatant 
library was constructed as described in Materials and Methods. Overnight cultures (0.4 l) of 
control colonies and unknown colonies were spotted on the nitrocellulose membrane in duplicate 
for the dot blotting screen. (A) A representative screening blot of the His384 library in the PTP 
system: boxes a1, a2, d1 and d2 have wtSrc-expressing cells as positive controls; boxes b1, b2, 
e1 and e2 have kdSrc-expressing cells as negative controls; boxes c1, c2, f1 and f2 have SD-
Src-expressing cells as negative controls. Other boxes have colonies expressing random His384 
mutants. (B) A representative screening blot of the His384 library in the non-PTP system.  The 
arrangement of colonies is the same as in Fig. 3A.
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Figure 4. Relative catalytic activity of Src His384 mutants. A. Coomassie blue staining of 
selected purified His384 mutant proteins. B. The catalytic activity of His384 mutants toward an 
artificial substrate, polyE4Y was determined. The wtSrc activity (210 min-1) is taken as 100%, 
and the activity of all other mutants was expressed as a percentage of that of the wtSrc. The 
kinase activities of each mutant can be found in the Supplementary Information. The wtSrc is 
represented by His as the wtSrc has His at the 384 position, and all other variants are represented 
by the residue at this position. 
Figure 5. Representative screening results of the Arg385 mutant library. The Arg385 mutant 
library was constructed as described in the Materials and Methods section. Colony screening was 
performed as described in the legend to Fig. 3. (A) A representative screening blot of the Arg385 
library in the PTP system. Boxes a1 and a2 have wtSrc expressing cells as positive controls; 
Boxes b1 and b2 have kdSrc-expressing cells as negative controls; Boxes c1 and c2 have S-Src 
expressing cells as negative controls. The other boxes have random Arg385 mutant cells. (B) A 
representative screening blot of the Arg385 library in the non-PTP system.  Colony arrangement 
is the same as in Fig. 5A.
Figure 6. Relative catalytic activity of Src Arg385 mutants. A. Coomassie staining of purified 
Arg385 mutants fractionated on SDS-PAGE. B. The kinase activity of selected Arg385 mutants 
toward an artificial substrate, polyE4Y was determined. The assay was performed as described in 
Materials and Methods and the legend to Fig. 4. Detailed information on the kinase mutants is 
given in Supplementary Information.
Figure 7. Representative screening results of the Asp386 mutant library. The Asp386 mutant 
library was constructed as described in Materials and Methods. (A) A representative screening 
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blot of the Asp386 library in the PTP system. Boxes a1, a2, d1 and d2 have wtSrc-expressing 
cells as positive controls; Boxes b1, b2, e1 and e2 have kdSrc-expressing cells as negative 
controls; boxes c1, c2, f1 and f2 have S-Src-expressing cells as negative controls. Other boxes 
have random Asp386 mutant-expressing colonies. (B) A representative screening blot of Asp386 
library in the non-PTP system. The colony arrangement is identical to that in Fig. 7A.
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Kinase activity determination for His384 mutants. (Complementary to Figure 4)
wtsrc R385T R385K R385V R385N R395A R385S R385L R385G R385C
Assay 1 (min-1)200.25 62.43 100.15 187.16 182.38 55.66 36.57 75.00 40.02 155.54
Assay 2 (min-1)207.50 79.77 82.78 181.76 197.85 62.78 36.26 80.12 48.14 150.71
Assay 3 (min-1)222.10 51.75 91.51 169.28 176.15 57.59 35.54 70.89 33.18 134.79
mean 209.95 64.65 91.48 179.40 185.46 58.68 36.13 75.34 40.45 147.02
standard error 6.43 8.16 5.01 5.29 6.45 2.13 0.30 2.67 4.32 6.27
Relative activity (% of wt)100.00 30.79 43.56 85.43 88.31 27.94 17.20 35.87 19.26 70.01
standard error 0.00 3.89 2.39 2.52 3.07 1.01 0.14 1.27 2.06 2.98
Kinase activity determination for Arg385 mutants. (Complementary to Figure 6)
wtsrc H384F H384S H384V H384L H384I H384G H384Q H384Y H384T
Assay 1 (min-1)200.25 21.23 9.28 -2.57 1.43 2.34 0.51 34.24 17.08 12.70
Assay 2 (min-1)207.50 13.18 4.76 3.53 0.94 0.34 0.13 23.21 8.58 8.09
Assay 3 (min-1)222.10 29.63 2.56 2.67 4.43 0.97 0.45 32.49 13.51 16.91
mean 209.95 21.35 5.53 1.21 2.27 1.22 0.36 29.98 13.06 12.57
standard error 6.43 4.75 1.98 1.91 1.09 0.59 0.12 3.42 2.47 2.55
Relative activity (% of wt)100.00 10.17 2.63 0.57 1.08 0.58 0.17 14.28 6.22 5.98
standard error 0.00 2.26 0.94 0.91 0.52 0.28 0.06 1.63 1.17 1.21
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